Guselkumab Tremfya |
Formulary
|
for treating moderately to severely active ulcerative colitis
for previously treated moderately to severely active Crohn's disease |
![]() ![]() |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Mirikizumab |
Formulary
|
100mg/ml solution for injection pre-filled pen, 300mg/15ml concentrate for solution for infusion vials For treatment of moderately to severely active ulcerative colitis. For treating moderately to severely active Crohn's disease. |
![]() ![]() |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Risankizumab Skyrizi® |
Formulary
|
Solution for injection pre-filled syringes 150mg/mL Crohn's disease - TA888 Moderately to severely active ulcerative colitis - TA998 |
![]() ![]() |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Ustekinumab |
Formulary
|
Concentrate for solution for infusion 130mg Solution for injection 45mg Pre-filled syringe 45mg, 90mg |
![]() ![]() |
![]() ![]() ![]() ![]() ![]() ![]() |